Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Avacta Group (AVCT) Share News

Avacta Group Appoints Roche's Jose Saro As Chief Medical Officer

12th Dec 2018 11:14

LONDON (Alliance News) - Reagents developer Avacta Group PLC on Wednesday appointed Jose Saro as chief medical officer to lead the firm's therapeutic development strategy.Saro brings 20 Read More

IP Group Investee Teams With LG Chem To Develop Affimer Drug Candidate

10th Dec 2018 08:52

LONDON (Alliance News) - IP Group PLC on Monday said its portfolio company Avacta Group PLC signed a development & license deal with LG Chem Life Sciences.IP Group currently holds a in Read More

Avacta Annual Revenue Increases But Loss Widens On Higher Expenses

2nd Oct 2018 09:42

LONDON (Alliance News) - Avacta Group PLC on Tuesday said its loss widened in its recently-ended financial year on higher costs, as it continues to progress Affimer.The reagents developer a Read More

FIL Reduces Avacta Stake To Below 5% Threshold After Deal (ALLISS)

23rd Aug 2018 17:38

LONDON (Alliance News) - Avacta Group PLC said Thursday that FIL Ltd decreased its stake in the biotechnology company to below 5% after a transaction on Tuesday.FIL lowered its holding to a Read More

Lombard Odier Asset Management Lowers Holding In Avacta (ALLISS)

23rd Aug 2018 14:20

LONDON (Alliance News) - Avacta Group PLC on Thursday said Lombard Odier Asset Management Europe Ltd reduced its holding in the biotechnology company.In a transaction on Tuesday, Lombard to Read More

UPDATE: Avacta Raises GBP12 Million To Fund New Drug Development (ALLISS)

30th Jul 2018 18:17

LONDON (Alliance News) - Biotherapeutics firm Avacta Group PLC late Monday said it raised GBP11.6 million before expenses to help fund new drug development partnerships.Early on Monday, to Read More

Avacta Sets GBP11.4 Million Share Offer To Fund New Drug Development (ALLISS)

30th Jul 2018 12:48

LONDON (Alliance News) - Biotherapeutics firm Avacta Group PLC on Monday said it plans to raise GBP11.4 million in a share placing and subscription to help fund new drug development is to place at Read More

Avacta Appoints Ex-Immunocore Boss Eliot Forster As Chairman

11th Jun 2018 10:48

LONDON (Alliance News) - Biotechnology firm Avacta Group PLC said Monday it appointed ex-Immunocore Ltd boss Eliot Forster as its non-executive chairman.Forster served as Immunocore CEO in Read More

Avacta Says Non-Executive Director Michael Albin To Stand Down Friday

29th Mar 2018 13:58

LONDON (Alliance News) - Avacta Group PLC, a healthcare products company that specialises in Affimer products that bind molecules together, said Thursday that non-executive be Read More

DIRECTOR DEALINGS: Avacta Chief Executive Officer Smith Buys Shares

13th Mar 2018 14:26

LONDON (Alliance News) - Avacta Group PLC said its Chief Executive Officer Alastair Smith bought shares in the biotechnology company in transaction on Tuesday.Smith at Read More

Avacta Adds Cancer Stem Cell Specialist Evan To Scientific Board

7th Nov 2016 09:41

Read More

Avacta Reports Good First Results From Affimer Pre-Clinical Trials

22nd Sep 2016 07:57

Read More

Avacta-Leeds University Partnership Gets GBP3.8 Million Grant

10th Aug 2016 07:43

Read More

Avacta Collaborating With Glythera To Develop Antibody Drugs

14th Jul 2016 08:34

Read More

Avacta Identifies Affimer Proteins For Possible Zika Virus Tests

22nd Jun 2016 06:37

Read More

Avacta Forms Partnership With Mologic To Develop Point-Of-Care Tests

13th Jun 2016 08:23

Read More

DIRECTOR DEALINGS: Avacta Chief Operating Officer Buys Shares

29th Apr 2016 14:37

Read More

Avacta Making Good Progress On Programmes As Interim Loss Widens

25th Apr 2016 08:22

Read More

Avacta Group Hails Milestone In Multi-Affimer Production

19th Apr 2016 09:27

Read More

Earnings, Trading Statements Calendar - Week Ahead

18th Apr 2016 15:05

Read More

FTSE 100 Latest
Value8,809.74
Change53.53